Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 421-432 of 4,306
Drug study icon
CompletedNCT00212771

Asenapine Using an Active Control for schizophrenia

This study is completed. It is testing asenapine Using an Active Control for schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.Over 18 Years
Countries
Sponsor
Organon and Co
Condition
Schizophrenia
Drug study icon
CompletedNCT01490086

RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Philadelphia
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, India, Malaysia, ...
Sponsor
Reviva Pharmaceuticals
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT05157620

Exercise-based Program for Rehabilitation of Veterans With Severe Mental Illness

This study is looking at whether Yoga-based Exercise (YE) can help people with Schizophrenia, Schizoaffective, or bipolarity 1. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.

In Pittsburgh
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, BipolarityBehavioralFrom 18 Years to 70 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Schizophrenia, Bipolarity
Other study type icon
RecruitingISRCTN71800376

Sleeping Better

This observational study is following people with Sleep difficulties in at ultra-high risk of psychosis and diagnosed with non-affective psychosis or Mental and Behavioural Disorders to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherOver 14 Years
Countries
United Kingdom
Sponsor
University of Oxford
Condition
Schizophrenia
Other study type icon
RecruitingNCT07616999

A 20-Year Follow-up of First Episode Psychosis: Longitudinal Effects of Early Treatment Strategies and Relapse

This summary needs review. Please check the official study record and contact the research team for details.

In Hong Kong
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 65 Years
Countries
China
Sponsor
The University of Hong Kong
Condition
Schizophrenia
Drug study icon
RecruitingNCT06585787

KarXT for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in France, in Belgium, ...

Multiple locations, including Gilbert
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 55 Years to 90 Years
Countries
United States, France, Belgium, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Drug study icon
RecruitingNCT07231497

Cognitive Strategies in Early Psychosis 1

This summary needs review. Please check the official study record and contact the research team for details.

In Minneapolis
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 35 Years
Countries
United States
Sponsor
University of Minnesota
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.